Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Esbjerg
Clinical trial register · Denmark

Clinical Trials in Esbjerg, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Denmark and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 2469 matching records held by the registry are in this view. Synced 16 Oct 2026, 03:17 UTC
2469
Studies in scope
all four open statuses
1395
Recruiting now
open to new participants
438
Lead sponsors
across recruiting studies
Top sites
Copenhagen 974 Aarhus 586 Odense 441 Aalborg 384 Herlev 314
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Esbjerg Hospital - University Hospital of Southern Denmark14 Odense University Hospital9 University of Aarhus7 AstraZeneca7 Novartis Pharmaceuticals6
Site location
Copenhagen974 Aarhus586 Odense441 Aalborg384 Herlev314
All 128 locations
Target enrolment
to

Trials with a site in Esbjerg

111 of 2469 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Denmark
Start
Not yet open
Danish Trial of Weight Loss to Reduce Atrial Fibrillation Progression
NCT07816744Atrial Fibrillation (AF), Obesity & Overweight
Axel Brandes
Not applicable
480
Copenhagen, Esbjerg
2026-10-01
Not yet open
Point-of-Care Ultrasound for Diagnosing Abdominal Pain in the Emergency Department
NCT07849569Emergency Medicine, POCUS, Abdominal Pain (AP), Acute Abdominal Pain
University of Aarhus
Not applicable
508
Esbjerg, Horsens, Køge
2026-10-01
Not yet open
The Role of Autoantibodies Against G-protein Coupled Receptors in Obesity
NCT07542327Obesity, Obesity & Overweight, Obesity Type 2 Diabetes Mellitus, Obesity and Obesity-related Medical Conditions
Claus Bogh Juhl
Observational
160
Esbjerg
2026-09-01
Not yet open
Rapid or Ultra-rapid Diagnosis of Myocardial Infarction Using High-Sensitivity Cardiac Troponin on Hospital Presentation
NCT07727135Coronary Syndrome, Acute, Myocardial Infarction, Coronary Artery Disease, Cardiovascular Diseases
Herlev and Gentofte Hospital
Not applicable
28,000
Aalborg, Bispebjerg, Esbjerg, Gødstrup, Herlev, Hillerød, Hvidovre, Nykøbing Falster
2026-09-01
Not yet open
Oral Switch in Pediatric Bloodstream Infections
NCT07791914Bloodstream Infection, Bacteremia Sepsis
Ulrikka Nygaard
Phase 4
150
Aabenraa, Aalborg, Aarhus, Copenhagen, Esbjerg, Gødstrup, Herlev, Hillerød
2026-09-01
Recruiting
AstraZeneca
Phase 3
2,000
Aarhus N, Esbjerg, Gandrup, Herlev, Hillerød, Hvidovre, Odense
2026-07-06
Recruiting
Merck Sharp & Dohme LLC
Phase 2
750
Viborg, Gandrup, Esbjerg, Svendborg
2026-06-30
Not yet open
University of Southern Denmark
Not applicable
80
Esbjerg
2026-06-01
Active, closed
Novartis Pharmaceuticals
Phase 3
5,700
Aarhus N, Copenhagen, Esbjerg, Gistrup, Herlev, Roskilde, Viborg
2026-05-11
Recruiting
Bracing After Ankle Fracture
NCT07163091Ankle Fracture, Rehabilitation, Recovery
Odense University Hospital
Not applicable
1,400
Aabenraa, Aalborg, Aarhus, Copenhagen, Esbjerg, Herlev, Hillerød, Hvidovre
2026-04-23
Recruiting
Janssen Research & Development, LLC
Phase 3
530
Aarhus C, Esbjerg, Gistrup, Herlev, Hilleroed, Hvidovre, København NV, Odense C
2026-04-21
Active, closed
Novo Nordisk A/S
Phase 3
606
Køge, Esbjerg, Vejle
2026-04-21
By invitation
Evaluating the Use of an App in Pleural Disease: Algorithm-supported Clinical Decision Making Versus Usual Care
NCT07625176Pleural Diseases, Pneumothorax Spontaneous Primary, Pneumothorax Spontaneous Secondary, Pleural Effusion
Zealand University Hospital
Not applicable
828
Aalborg, Aarhus, Amager, Esbjerg, Hillerød, Hvidovre, Kolding, Køge
2026-04-01
Recruiting
Transabdominal and Laparoscopic Ultrasound in a Bariatric Setting
NCT07453186Gallstone Disease, Ultrasonic Diagnosis, Bariatric Patients Undergoing Bariatric Surgery
Esbjerg Hospital - University Hospital of Southern Denmark
Not applicable
130
Esbjerg
2026-04-01
Recruiting
The Effect of Music During Colonoscopy
NCT07454993Pain, Pain Management
Esbjerg Hospital - University Hospital of Southern Denmark
Not applicable
1,042
Esbjerg
2026-03-12
Recruiting
Blood Clotting Markers and Heart Ultrasound in People With Device-Detected Atrial Fibrillation
NCT07713615Device-detected Atrial Fibrillation, Subclinical Atrial Fibrillation, Atrial High Rate Episodes
Andreas Sjøholm-Christensen
Observational
222
Esbjerg
2026-02-27
Recruiting
Does AI Make Clinicians More Appropriately Confident? A Randomized Study in Preterm Birth Prediction
NCT07402668Preterm Birth, Artificial Intelligence (AI) in Diagnosis
Copenhagen University Hospital, Rigshospitalet
Not applicable
125
Aabenraa, Aalborg, Aarhus, Copenhagen, Esbjerg, Gødstrup, Herlev, Hillerød
2026-02-03
Recruiting
Novartis Pharmaceuticals
Phase 3
1,275
Aarhus N, Esbjerg, Glostrup Municipality, Odense C
2025-11-11
Recruiting
Esbjerg Hospital - University Hospital of Southern Denmark
Not applicable
250
Aabenraa, Esbjerg, Odense
2025-10-03
Recruiting
Alnylam Pharmaceuticals
Phase 3
11,000
Esbjerg, Holbæk, Hvidovre, København S, Odense, Vejle
2025-09-06
Not yet open
MOdel-Informed Precision Dosing of Ustekinumab and VEdolizumab in Inflammatory Bowel Disease
NCT06788340Inflammatory Bowel Diseases, Crohn Disease, Ulcerative Colitis
Odense University Hospital
Phase 4
166
Aalborg, Esbjerg, Hvidovre, Nyborg, Odense, Vejle
2025-09-01
Recruiting
Prehabilitation to Patients With Prostate Cancer
NCT07162987Prostate Cancer (Diagnosis)
Odense University Hospital
Not applicable
20
Esbjerg, Nyborg, Vejle
2025-08-04
Recruiting
Amgen
Phase 3
12,800
Aalborg, Aarhus N, Esbjerg, Gandrup, Herlev, Herning, Holbæk, Hvidovre
2025-07-25
Recruiting
Boehringer Ingelheim
Phase 3
11,800
Aarhus N, Esbjerg, Herlev, Herning, Hvidovre, Kolding, Slagelse
2025-07-22
Recruiting
Esbjerg Hospital - University Hospital of Southern Denmark
Observational
100
Esbjerg
2025-07-08
Recruiting
AstraZeneca
Phase 2
987
Aalborg, Aarhus, Esbjerg, Hvidovre, Odense C, Roskilde
2025-06-27
Recruiting
The Intensive Care Platform Trial
NCT06667999Intensive Care Patients, Intensive Care Unit Patients, Critical Illness
DrugAlbumin
Anders Perner
Phase 4
10,000
Aabenraa, Aalborg, Aarhus, Copenhagen, Esbjerg, Herlev, Herning, Hillerød
2025-06-26
Recruiting
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
NCT07037459Heart Failure With Preserved Ejection Fraction, Heart Failure With Mildly Reduced Ejection Fraction, Obesity
DrugMaridebart cafraglutide
Amgen
Phase 3
5,056
Aarhus N, Esbjerg, Frederiksberg, Herlev, Herning, Hvidovre, Roskilde
2025-06-25
Active, closed
A Phase III Study to Assess the Effect of AZD0780 on LDL-C in Patients With HeFH
NCT07000136Heterozygous Familial Hypercholesterolaemia
DrugAZD0780
AstraZeneca
Phase 3
473
Aarhus N, Copenhagen, Esbjerg, Herlev, Herning, Hvidovre, Viborg
2025-06-10
Recruiting
Tapering of Biologics in Chronic Rhinosinusitis With Nasal Polyps
NCT07187583Chronic Rhinosinusitis With Nasal Polyps
Copenhagen University Hospital, Rigshospitalet
Phase 4
135
Aalborg, Aarhus, Copenhagen, Esbjerg, Herning, Hillerød, Køge, Odense
2025-06-05
Recruiting
AstraZeneca
Phase 3
15,100
Aarhus N, Copenhagen, Esbjerg, Frederiksberg, Gandrup, Gistrup, Herlev, Herning
2025-06-04
Recruiting
University of Aarhus
Phase 4
5,076
Herning, Horsens, Viborg, Aalborg, Aabenraa, Esbjerg, Kolding, Odense
2025-05-01
Active, closed
Eli Lilly and Company
Phase 3
905
Esbjerg, Herlev, Herning, Hillerød, Køge
2025-04-25
Recruiting
FDG-PET/CT vs. CT for Monitoring Metastatic Breast Cancer
NCT06877949Metastatic Breast Cancer, Response Monitoring
Odense University Hospital
Not applicable
420
Aalborg, Aarhus, Copenhagen, Esbjerg, Herlev, Odense, Sønderborg, Vejle
2025-04-02
Recruiting
Type 1 Diabetes and Diabetes Distress
NCT06936280Diabetes Distress, Diabetes Mellitus Type 1
Odense University Hospital
Not applicable
100
Esbjerg, Odense, Sønderborg
2025-04-01
Recruiting
Esbjerg Hospital - University Hospital of Southern Denmark
Phase 2
105
Sønderborg, Esbjerg, Vejle
2025-03-27
Recruiting
AstraZeneca
Phase 3
11,300
Aarhus, Aarhus N, Copenhagen, Esbjerg, Frederiksberg, Gistrup, Herlev, Herning
2025-03-14
Recruiting
Esbjerg Hospital - University Hospital of Southern Denmark
Not applicable
165
Esbjerg, Odense C, Svendborg, Vejle
2025-02-26
Recruiting
Odense University Hospital
Phase 4
1,400
Aalborg, Copenhagen, Esbjerg, Herlev, Hillerød, Hvidovre, Odense
2025-02-21
Active, closed
Janssen Research & Development, LLC
Phase 3
552
Aarhus N, Esbjerg, Frederiksberg, Herning, Svendborg, Vejle
2025-02-21
Active, closed
Novo Nordisk A/S
Phase 3
400
Aarhus, Esbjerg, Hellerup, Hvidovre, Køge
2025-02-10
Recruiting
The Ventilation During In-hospital Cardiac Arrest Study
NCT06809309Cardiac Arrest (CA), In-Hospital Cardiac Arrest, Heart Arrest
University of Aarhus
Observational
900
Aabenraa, Aalborg, Aarhus, Esbjerg, Gødstrup, Hjørring, Horsens, Odense
2025-02-01
Recruiting
Intravenous Versus Oral Treatment of the Main Acute Infections
NCT06715306Respiratory Tract Infections, Urinary Tract Infections, Cellulitis
University of Southern Denmark
Not applicable
4,000
Aabenraa, Copenhagen, Esbjerg, Herlev, Hvidovre, Kolding
2025-01-15
Active, closed
Comparison Between ABP 692 and Ocrevus® (Ocrelizumab)
NCT06700343Relapsing-remitting Multiple Sclerosis (RRMS)
DrugOcrelizumab
Amgen
Phase 3
152
Aarhus N, Esbjerg, Glostrup Municipality
2025-01-13
Recruiting
Janssen Research & Development, LLC
Phase 3
750
Aarhus N, Esbjerg, Frederiksberg, Herning, Svendborg, Vejle
2025-01-09
Active, closed
Pfizer
Phase 3
1,035
Copenhagen, Aarhus, Esbjerg, Odense, Sønderborg
2025-01-06
Active, closed
Odense University Hospital
Phase 2
36
Esbjerg, Odense C
2024-11-04
Recruiting
GlaxoSmithKline
Phase 2
393
Esbjerg, Hvidovre, Odense C
2024-09-27
Recruiting
What Influence Re-participation in the Danish Colorectal Screening Program.
NCT07353632Colonoscopy, Screening Colonscopy, Pain
Esbjerg Hospital - University Hospital of Southern Denmark
Observational
8,000
Aabenraa, Esbjerg, Grindsted, Gødstrup, Holbæk, Køge, Nykøbing Falster, Slagelse
2024-09-23
Recruiting
Stroke Risk Assessment and Markers of Blood Clotting in Patients With Newly Diagnosed Non-valvular Atrial Fibrillation (NVAF), Who Have Not Received Oral Anticoagulation Therapy (OAC-therapy) Prior to Inclusion
NCT06949319Atrial Fibrillation (AF), Atrial Fibrillation (Prevention of Stroke), Atrial Fibrillation New Onset, Non Valvular Atrial Fibrillation
Nedim Tojaga
Observational
150
Esbjerg
2024-08-16
Active, closed
Astellas Pharma Global Development, Inc.
Phase 3
982
Aalborg, Esbjerg, Hillerød, Næstved, Sønderborg
2024-07-31
Active, closed
Novartis Pharmaceuticals
Phase 3
162
Esbjerg, Gandrup, Vejle
2024-06-28
Recruiting
University of Aarhus
Phase 3
236
Aalborg, Aarhus, Esbjerg, Herning, Kolding
2024-06-27
Active, closed
University of Aarhus
Phase 4
216
Aalborg, Aarhus, Esbjerg, Herning, Kolding
2024-05-27
Recruiting
Carsten Dirksen
Not applicable
500
Aarhus, Esbjerg, Hvidovre, Viborg
2024-05-08
Recruiting
Recovering From Bariatric Surgery: the Effects of Early Initiated and Supervised Mobilization
NCT06222151Postoperative Pain, Acute, Postoperative Pain, Chronic, Bariatric Surgery, Mobilization
Esbjerg Hospital - University Hospital of Southern Denmark
Not applicable
112
Esbjerg
2024-04-22
Active, closed
A Study to Investigate Long-term Safety and Tolerability of Tolebrutinib in Participants With Multiple Sclerosis.
NCT06372145Relapsing Multiple Sclerosis, Secondary Progressive Multiple Sclerosis, Progressive Relapsing Multiple Sclerosis
DrugTeriflunomide
Sanofi
Phase 3
2,500
Esbjerg, Holstebro, Odense
2024-04-16
Active, closed
AstraZeneca
Phase 3
2,554
Aalborg, Aarhus, Copenhagen E, Esbjerg, Herlev, Herning, Holbæk
2024-03-29
Active, closed
Takeda
Phase 2
213
Odense, Aalborg, Esbjerg, Hillerød, Hvidovre, Køge
2024-03-29
Active, closed
VIsualization of Coronary Artery Disease for Modification of RISK Factors
NCT06413641Coronary Artery Disease, Non-Obstructive Coronary Atherosclerosis
Aarhus University Hospital
Not applicable
273
Gødstrup, Aalborg, Aarhus, Esbjerg, Vejle
2024-03-12
Recruiting
Novartis Pharmaceuticals
Phase 2
502
Esbjerg, Hvidovre, Roskilde, Viborg
2024-03-07
Recruiting
Takeda
Phase 2
268
Odense, Esbjerg, Gistrup, Hillerød, Hvidovre, Køge
2024-03-05
Active, closed
Eli Lilly and Company
Phase 3
17,300
Aabenraa, Aarhus, Copenhagen, Esbjerg, Gandrup, Herlev, Holbæk, Vejle
2024-03-05
Recruiting
AstraZeneca
Phase 3
5,250
Aalborg, Esbjerg, Hvidovre, København NV, Næstved, Vejle
2024-02-21
By invitation
Coronary Computed Tomography Angiography In Rheumatoid Arthritis Study
NCT07363980Rheumatoid Arthritis, Atherosclerotic Ischemic Disease, Pulmonary Disease, Depressive Disorder
Ellen Margrethe Hauge
Observational
4,000
Aarhus, Esbjerg, Herning
2024-02-21
Recruiting
The Safe Fast Track Study
NCT06219486Emergency Department, Non-specific Complaints
Odense University Hospital
Not applicable
1,538
Esbjerg, Odense
2024-01-22
Recruiting
Strategy for Prompt and Effective Thoracentesis in the Emergency Department
NCT06180603Pleural Effusion, Pleural Diseases, Heart Failure
University of Aarhus
Not applicable
188
Aarhus, Gødstrup, Horsens, Randers, Aalborg, Esbjerg
2024-01-15
Active, closed
Sanofi
Phase 3
1,655
Esbjerg, Glostrup Municipality
2023-12-13
Recruiting
Early Initiated Vasopressor Therapy in the Emergency Department
NCT05931601Shock, Shock, Septic, Hypotension, Hypotension and Shock
DrugNoradrenaline
Odense University Hospital
Phase 3
320
Copenhagen, Esbjerg, Herning, Køge, Odense
2023-12-08
Recruiting
The Fourth Left Atrial Appendage Occlusion Study
NCT05963698Atrial Fibrillation, Stroke, Ischemic, Systemic Embolism
Hamilton Health Sciences Corporation
Not applicable
4,000
Viborg, Aarhus, Esbjerg, Copenhagen, Hjørring, Odense C
2023-11-30
Active, closed
Ad scientiam
Not applicable
336
Esbjerg, Glostrup Municipality, Viborg
2023-09-22
Active, closed
Maxillary Patient Specific Implants in Bimaxillary Orthognathic Surgery
NCT06297109Retrognathia, Malocclusion, Angle Class II
Esbjerg Hospital - University Hospital of Southern Denmark
Not applicable
60
Esbjerg
2023-09-12
Recruiting
Predictive Utility of a Short-term Improvement in Objectively Measured Physical Activity in Rheumatoid Arthritis (PUSIPA)
NCT06289114Rheumatoid Arthritis, Fibromyalgia, Secondary, Fatigue, Physical Inactivity
Esbjerg Hospital - University Hospital of Southern Denmark
Observational
100
Esbjerg
2023-09-01
Active, closed
Cryoneurolysis Prior to Total Knee Arthroplasty
NCT05840276Post Operative Pain, Knee Osteoarthritis, Opioid-Related Disorders
Esbjerg Hospital - University Hospital of Southern Denmark
Not applicable
100
Esbjerg
2023-08-30
By invitation
Palliative Care for Patients With Liver Cirrhosis
NCT05431946End of Life Care, Liver Cirrhosis, Nurse-Patient Relations, Quality of Life
Esbjerg Hospital - University Hospital of Southern Denmark
Observational
200
Esbjerg
2023-08-01
Active, closed
Copenhagen University Hospital, Rigshospitalet
Phase 4
220
Aalborg, Aarhus, Copenhagen, Esbjerg, Herning, Hillerød, Køge, Odense
2023-04-27
Active, closed
Herlev and Gentofte Hospital
Phase 4
5,000
Aarhus, Copenhagen, Copenhagen NV, Copenhagen S, Copenhagen Ø, Esbjerg, Frederikssund, Gentofte Municipality
2023-04-01
Active, closed
Herlev and Gentofte Hospital
Phase 4
11,000
Aalborg, Aarhus, Ballerup Municipality, Copenhagen, Copenhagen NV, Copenhagen S, Copenhagen Ø, Esbjerg
2023-04-01
Active, closed
A Study of Inclisiran to Prevent Cardiovascular Events in High-risk Primary Prevention Patients.
NCT05739383Primary Prevention of Atherosclerotic Cardiovascular Disease
DrugInclisiran
Novartis Pharmaceuticals
Phase 3
14,012
Aarhus N, Copenhagen S, Esbjerg, Gandrup, Herlev, Herning, Kobenhavn N V, Roskilde
2023-03-09
Active, closed
Lars Wiuff Andersen
Phase 4
778
Aabenraa, Aalborg, Aarhus, Bispebjerg, Copenhagen, Esbjerg, Gentofte Municipality, Gødstrup
2023-02-06
Active, closed
Amgen
Phase 3
7,297
Aalborg, Aarhus N, Copenhagen O, Esbjerg, Gandrup, Herlev, Herning, Holbæk
2022-12-14
Active, closed
Ionis Pharmaceuticals, Inc.
Phase 3
885
Aalborg, Aarhus, Esbjerg, Viborg
2022-12-13
Recruiting
Sven Löffeler
Phase 3
980
Copenhagen, Esbjerg, Odense
2022-11-04
Active, closed
Novo Nordisk A/S
Phase 3
3,400
Køge, Esbjerg, Aarhus N, Hellerup, Hvidovre
2022-11-01
Active, closed
Effect of Single vs Multiple Prophylactic Antibiotic Doses on PJI Following Primary THA in Patients With a Fracture
NCT05530174Fracture of Hip, Total Hip Arthroplasty, Prosthetic-joint Infection, Fracture Acetabular
Soren Overgaard
Not applicable
2,000
Aabenraa, Aalborg, Aarhus, Aarhus C, Brøndby, Copenhagen NV, Copenhagen Ø, Esbjerg
2022-09-01
Recruiting
Compassionate Communication and Advance Care Planning to Improve End of Life Care in Treatment of Hematological Disease (ACT)
NCT05444348Multiple Myeloma, Myelodysplastic Syndromes, Lymphoma, Acute Myeloid Leukemia
Christoffer Johansen
Not applicable
920
Aalborg, Aarhus, Esbjerg, Herning, Odense, Roskilde, Vejle
2022-08-01
Active, closed
Breastfeeding - a Good Start Together
NCT05311631Breastfeeding, Breastfeeding, Exclusive
University of Copenhagen
Not applicable
5,010
Aabenraa, Aabybro, Aars, Assens, Billund, Esbjerg, Fredericia, Frederikshavn
2022-04-26
Recruiting
Scandinavian Humeral Diaphyseal Fracture Trial
NCT04574336Fracture Humerus of Shaft
Kolding Sygehus
Not applicable
287
Aabenraa, Aarhus, Copenhagen, Esbjerg, Farsø, Gentofte Municipality, Hillerød, Holbæk
2022-04-04
Active, closed
NewAmsterdam Pharma
Phase 3
9,541
Aalborg, Copenhagen, Esbjerg, Herning, Viborg
2022-02-07
Active, closed
Janssen Research & Development, LLC
Phase 3
350
Esbjerg, Hilleroed
2022-01-19
Active, closed
Novartis Pharmaceuticals
Phase 3
17,004
Herning, Aarhus N, Esbjerg, Glostrup Municipality, Herlev, Hjørring, Roskilde, Svendborg
2021-11-23
Active, closed
University of Southern Denmark
Not applicable
90
Esbjerg
2021-09-01
Active, closed
Ida Bruun Kristensen
Phase 2
50
Aalborg, Esbjerg, Gødstrup, Odense
2021-08-18
By invitation
Viatris Innovation GmbH
Phase 3
25,000
Aarhus, Esbjerg, Gistrup, Hellerup, Herning, Odense, Roskilde, Svendborg
2021-08-14
Recruiting
University of Aarhus
Not applicable
102
Aarhus N, Esbjerg, Farsø, Silkeborg, Viborg
2021-05-28
Active, closed
Non-inferiority Study of Ocrelizumab and Rituximab in Active Multiple Sclerosis
NCT04688788Relapsing Remitting Multiple Sclerosis, Secondary Progressive Multiple Sclerosis, Primary Progressive Multiple Sclerosis
DrugsFexofenadine·Paracetamol·Ocrelizumab·Ruxience
Copenhagen University Hospital, Rigshospitalet
Phase 3
600
Glostrup Municipality, Aalborg, Aarhus, Esbjerg, Herlev, Hillerød, Holstebro, Kolding
2021-04-28
Active, closed
Hoffmann-La Roche
Phase 3
751
Esbjerg, Sønderborg
2021-03-24
Active, closed
German CLL Study Group
Phase 3
897
Aalborg, Aarhus, Copenhagen, Esbjerg, Holstebro, Odense, Roskilde, Vejle
2021-03-01
Active, closed
Local Antibiotics for Breast Implants
NCT04731025Implant Complication, Implant Infection, Implant Site Infection, Implant Capsular Contracture
Mikkel Herly
Phase 3
1,003
Aalborg, Aarhus, Copenhagen, Esbjerg, Herlev, Odense, Roskilde, Vejle
2021-01-27
Recruiting
Claus Bogh Juhl
Observational
2,700
Esbjerg
2020-09-01
Recruiting
Nordic Lymphoma Group
Phase 3
300
Aalborg, Aarhus, Copenhagen, Esbjerg, Holstebro, Odense, Roskilde, Vejle
2020-08-19
Recruiting
Delayed-immediate Versus Delayed Breast Reconstruction in Breast Cancer Patients With Mastectomy and Radiation Therapy
NCT03730922Breast Neoplasm Female, Complication of Radiation Therapy, Breast Implant; Complications
Danish Breast Cancer Cooperative Group
Not applicable
590
Aabenraa, Aalborg, Aarhus, Copenhagen, Esbjerg, Roskilde, Vejle, Viborg
2020-01-01
Active, closed
NordicTrip, a Translational Study of Preoperative Chemotherapy in TNBC
NCT04335669Breast Cancer, Triple Negative Breast Neoplasms
Lund University Hospital
Phase 3
325
Vejle, Aalborg, Copenhagen, Esbjerg, Hillerød, Næstved, Sønderborg
2019-12-20
By invitation
Diagnosing Minimal Hepatic Encephalopathy
NCT05433948Hepatic Encephalopathy, Liver Cirrhosis
Esbjerg Hospital - University Hospital of Southern Denmark
Observational
550
Esbjerg
2019-12-01
Recruiting
The Danish Warfarin-Dialysis Study - Safety and Efficacy of Warfarin in Patients With Atrial Fibrillation on Dialysis
NCT03862859Atrial Fibrillation and Flutter, Stroke, Major Bleed, End-stage Renal Disease
DrugWarfarin
Nicholas Carlson
Phase 4
718
Herlev, Hillerød, Aalborg, Aarhus, Copenhagen, Esbjerg, Holbæk, Holstebro
2019-10-09
Recruiting
Low INR to Minimize Bleeding With Mechanical Valves Trial
NCT03636295Bleeding Post-mechanical Valve Replacement, Thromboembolism Post-mechanical Valve Replacement
DrugWarfarin
Population Health Research Institute
Phase 3
2,625
Esbjerg, Aabenraa, Aarhus
2019-09-05
Recruiting
Population Health Research Institute
Phase 4
2,270
Aarhus, Esbjerg, Odense
2019-06-14
Recruiting
Prognostic Significance of Fatty Liver Disease in Bariatric Patients
NCT03535142Non-Alcoholic Fatty Liver Disease, Metabolic Encephalopathy, Obesity, Morbid, Non-alcoholic Steatohepatitis
Esbjerg Hospital - University Hospital of Southern Denmark
Not applicable
1,200
Esbjerg
2018-08-15
Recruiting
Registry for Patients With X-Linked Hypophosphatemia
NCT03193476X-Linked Hypophosphatemia
Kyowa Kirin Pharmaceutical Development Ltd
Observational
1,489
Aalborg, Aarhus, Esbjerg, København Ø, Odense
2017-09-12
Active, closed
Eli Lilly and Company
Phase 3
5,637
Copenhagen, København Ø, Aarhus, Herning, Aalborg, Næstved, Esbjerg, Odense
2017-07-12
Active, closed
Karolinska Institutet
Not applicable
2,766
Aabenraa, Aalborg, Aarhus, Copenhagen, Esbjerg, Lillebaelt, Odense, Randers
2015-01-27
Rows per page Showing 1–111 of 111
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Danish investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 16 October 2026. https://priyalifescience.com/clinical-trials-denmark/city/esbjerg

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Denmark and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 2,469 studies in total at the last sync on 16 Oct 2026, 03:17 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 111 of those studies with a site in Esbjerg.

How many clinical trials are recruiting in Esbjerg?

56 of the 111 studies on this page are recruiting new participants as of the 16 Oct 2026, 03:17 UTC sync. A further 7 have not yet opened recruitment, 43 are active but closed to new participants, and 5 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Esbjerg), 111 studies
PhaseStudiesRecruitingShare
Phase 3441639.6%
Not applicable332029.7%
Phase 413611.7%
Observational12810.8%
Phase 2968.1%

Most active sponsors

Lead sponsors with the most studies (Esbjerg)
Lead sponsorStudiesRecruiting
Esbjerg Hospital - University Hospital of Southern Denmark1410
Odense University Hospital97
AstraZeneca75
University of Aarhus75
Novartis Pharmaceuticals62
Amgen42
Copenhagen University Hospital, Rigshospitalet42
Janssen Research & Development, LLC42
Eli Lilly and Company30
Herlev and Gentofte Hospital30
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.